Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission

about

Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission

Item

http://www.wikidata.org/entity/Q57898894

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2018

@uk

name

Ten-year outcome of patients w ...... on in first complete remission

@en

Ten-year outcome of patients w ...... on in first complete remission

@nl

type

Item

label

Ten-year outcome of patients w ...... on in first complete remission

@en

Ten-year outcome of patients w ...... on in first complete remission

@nl

prefLabel

Ten-year outcome of patients w ...... on in first complete remission

@en

Ten-year outcome of patients w ...... on in first complete remission

@nl

P1476

Ten-year outcome of patients w ...... on in first complete remission

@en

P2093

Andrew J Carroll

http://www.w3.org/2001/XMLSchema#string

Ann-Kathrin Eisfeld

http://www.w3.org/2001/XMLSchema#string

Bayard L Powell

http://www.w3.org/2001/XMLSchema#string

Deedra Nicolet

http://www.w3.org/2001/XMLSchema#string

Dimitrios Papaioannou

http://www.w3.org/2001/XMLSchema#string

Gail J Roboz

http://www.w3.org/2001/XMLSchema#string

Heiko Becker

http://www.w3.org/2001/XMLSchema#string

Jonathan E Kolitz

http://www.w3.org/2001/XMLSchema#string

Joseph O Moore

http://www.w3.org/2001/XMLSchema#string

Lisa J Sterling

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic Classification and Prognosis in Acute Myeloid Leukemia.

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials.

Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.

Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.

Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022.

Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.

Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

P304

1645-1650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOODADVANCES.2017015222

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29991495

http://www.w3.org/2001/XMLSchema#string

P932

6039651

http://www.w3.org/2001/XMLSchema#string